| 2023 | 2022 | |||
|---|---|---|---|---|
| Gross margin | -9,3 k € | +41.9% | -15,9 k € | |
| EBITDA | -11,6 k € | +27.1% | -16,0 k € | |
| Operating profit | -14,5 k € | +52.7% | -30,5 k € | |
| Profit/loss | -14,5 k € | +52.5% | -30,6 k € | |
| Equity | -40,2 k € | -56.8% | -25,6 k € | |
| Total assets | 29,5 k € | -6.4% | 31,5 k € | |
| Cash | 1,6 k € | — | ||
| Debts | 69,6 k € | +21.9% | 57,1 k € | |
Source: Belgian Official Gazette
Private limited company · Ixelles · incorporated on 15/07/2021
Private limited company loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
PharmaDEXI is a Private limited company incorporated in 2021. Its registered office is in Ixelles.